doi: 10.1111/j.1476-5381.1979.tb16090.x.
Anti-aggregatory effect of prostacyclin (PGI2) in vivo
- PMID: 378308
- PMCID: PMC2043836
- DOI: 10.1111/j.1476-5381.1979.tb16090.x
Item in Clipboard
Anti-aggregatory effect of prostacyclin (PGI2) in vivo
Br J Pharmacol.
1979 May.
Abstract
Prostacyclin (PGI2) when infused intravenously reduced the mortality of rabbits given high intravenous doses of arachidonic acid (AA). Prostaglandins E1 and D2 were ineffective. Indomethacin pretreatment abolished the toxic AA effect. Since the lethal effect of AA is partly due to the formation of platelet aggregates it is concluded that PGI2 is a most potent anti-aggregatory prostaglandin in vivo.
Similar articles
-
Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.Arch Int Pharmacodyn Ther. 1981 Feb;249(2):306-8. Arch Int Pharmacodyn Ther. 1981. PMID: 7013724 No abstract available.
-
The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.Thromb Haemost. 1979 Apr 23;41(2):425-35. Thromb Haemost. 1979. PMID: 382434
-
Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.Prostaglandins. 1978 Sep;16(3):373-88. doi: 10.1016/0090-6980(78)90216-2. Prostaglandins. 1978. PMID: 364545
-
Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.Adv Exp Med Biol. 1985;192:109-25. doi: 10.1007/978-1-4615-9442-0_9. Adv Exp Med Biol. 1985. PMID: 2871707 Review. No abstract available.
-
Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.Circulation. 1980 Dec;62(6 Pt 2):V19-25. Circulation. 1980. PMID: 7002350 Review.
Cited by
-
Epoprostenol sodium (prostacyclin) infusion in acute myocardial infarction.Br Heart J. 1986 Nov;56(5):428-32. doi: 10.1136/hrt.56.5.428. Br Heart J. 1986. PMID: 3539163 Free PMC article. Clinical Trial.
-
Cell detachment and metastasis.Cancer Metastasis Rev. 1983;2(2):111-27. doi: 10.1007/BF00048965. Cancer Metastasis Rev. 1983. PMID: 6352010 Review.
-
Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.Br Heart J. 1994 Jan;71(1):7-15. doi: 10.1136/hrt.71.1.7. Br Heart J. 1994. PMID: 8297699 Free PMC article. Clinical Trial.
-
Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.Br J Pharmacol. 1982 May;76(1):3-31. doi: 10.1111/j.1476-5381.1982.tb09186.x. Br J Pharmacol. 1982. PMID: 7044460 Free PMC article. Review. No abstract available.
-
Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.Postgrad Med J. 1983 Dec;59(698):743-58. doi: 10.1136/pgmj.59.698.743. Postgrad Med J. 1983. PMID: 6361717 Free PMC article. Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
